Welcome to our dedicated page for AMETEK INC/ SEC filings (Ticker: AME), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AMETEK INC/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AMETEK INC/'s regulatory disclosures and financial reporting.
AMETEK Senior VP and Controller Robert Amodei received new equity awards. He was granted stock options for 1,130 shares of common stock at an exercise price of $212.77 per share. These options vest in three equal annual installments beginning on March 18, 2027 and expire on March 18, 2036.
Amodei also received 360 shares of common stock at $212.77 per share as restricted stock under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. Of these, 69 shares were withheld to cover taxes, with the remainder added to his direct holdings, which total 44,221 common shares after the transactions. He also holds 3,149 shares indirectly through a 401(k) plan and 711 shares in a Common Stock SERP account.
AMETEK executive Tony J. Ciampitti, President of Electronic Instruments, received new equity awards. He was granted stock options for 4,110 shares of common stock at an exercise price of $212.77 per share, which become exercisable in three equal annual installments beginning on March 18, 2027. He also received 1,300 shares of restricted common stock valued at $212.77 per share, while 229 shares were withheld to pay taxes. Following these transactions, he directly holds 56,189 shares of common stock, plus 4,110 stock options, with additional holdings of 9,465 units in a SERP account and 2,776 shares through a 401(k) plan.
Oberton Karleen Marie reported acquisition or exercise transactions in this Form 4 filing.
AMETEK Inc. director Karleen Marie Oberton received a grant of 950 shares of Common Stock, constituting restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. The award was valued at $212.77 per share on the grant date. Following this grant, she directly holds 5,640 shares.
AMATO THOMAS A reported acquisition or exercise transactions in this Form 4 filing.
AMETEK director Thomas A. Amato received a grant of 950 shares of restricted common stock, valued at $212.77 per share, under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. This is a compensation-related award rather than an open-market purchase.
After the grant, he directly holds 5,010 common shares. The filing also shows an additional 6,500 common shares held indirectly by a trust, giving him both direct and indirect exposure to AMETEK stock.
AMETEK Inc. director Stefany Suzanne received a grant of 950 shares of Common Stock as a restricted stock award. The award was issued at a value of $212.77 per share under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. Following this compensation-related acquisition, she directly holds 5,030 AMETEK shares.
AMETEK Inc. director Dean Seavers reported an equity award of company stock. On this Form 4, he acquired 950 shares of AMETEK common stock as a grant or award valued at $212.77 per share. The shares constitute restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan.
Following this award, Seavers directly holds 5,600 shares of AMETEK common stock. This transaction reflects compensation in stock rather than an open-market purchase.
AMETEK director Anthony James Conti received a grant of company stock as compensation. He acquired 950 shares of AMETEK common stock on March 18, 2026, recorded at $212.77 per share, as restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. Following this award, he directly owns 30,298 common shares. This was a compensation-related grant, not an open-market purchase.
Carpenter Tod E. reported acquisition or exercise transactions in this Form 4 filing.
AMETEK director Tod E. Carpenter received a grant of 950 shares of common stock, valued at $212.77 per share, as equity compensation. The award is restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan and is held directly.
After this grant, Carpenter directly owns 10,480 AMETEK common shares. Restricted stock generally vests over time or upon meeting conditions, aligning a director’s interests with long-term shareholder value rather than representing an open-market purchase.
AMETEK director Gretchen W. McClain received 950 shares of common stock as a restricted stock award at $212.77 per share under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. This is a compensation-related grant, not an open‑market purchase.
McClain now holds 18,981 shares of common stock directly after this award. She also acquired 52 additional common stock units through dividend reinvestments in the Deferred Compensation Plan, bringing her deferred compensation holdings to 3,199 units. These transactions reflect routine equity compensation and plan reinvestments rather than discretionary trading.